Money · Federal contracts

PPD DEVELOPMENT LP

$2,945,851 in contract dollars, fiscal year 2027Confirmed from the official record
Unique Entity ID (UEI)
ZANENSW6C665
Parent company
JAGUAR HOLDING COMPANY II (UEI MVQ8HNL9ULH3)
Registered address
WILMINGTON, NC, district NC-07
Other names on record
APPLIED BIOSCIENCE INTERNATIONAL, PPD DEVELOP; PHARMACEUTICAL PRODUCT DEVELOP; PHARMACEUTICAL PRODUCT DEVELOPMENT; PHARMACEUTICAL PRODUCT DEVELOPMENT INC; PHARMACEUTICAL PRODUCT DEVELOPMENT INC.; PHARMACEUTICAL PRODUCT DEVELOPMENT, INC; PHARMACEUTICAL PRODUCT DEVELOPMENT, INC.; PPD DEVELOPMENT, L.P.; PPD DEVELOPMENT, LP

Dollars are contract obligations in the fiscal year, as USAspending adds them up from each award's transactions. A contract's full value can be larger and run over several years. A figure below zero is money taken back from contracts signed earlier.

Source: USAspending.gov, the Treasury’s public record of federal spending. Our copy was saved November 17, 2026.

The largest vendors

Which agencies pay this vendor, and where the work is done

Fiscal year 2027: $2,945,851

Contract dollars by awarding agency, Fiscal year 2027
AgencyContract dollars
Department of Health and Human Services$2,945,851
Contract dollars by House district, Fiscal year 2027
District where the work is doneContract dollars
NC-07David Rouzer$2,945,851

Fiscal year 2026: $50,501,887.75

Contract dollars by awarding agency, Fiscal year 2026
AgencyContract dollars
Department of Health and Human Services$50,501,887.75
Contract dollars by House district, Fiscal year 2026
District where the work is doneContract dollars
NC-07David Rouzer$50,515,379.47
MD-08Jamie Raskin-$13,491.72

Largest awards

The largest contract awards with activity from October 1, 2025 to September 30, 2027, by each award's total amount over its whole life. 0 rows of the answer belong to related companies and are left out.

Largest contract awards, by each award's total over its life
AwardAgencyWhere the work is doneAward totalStart
75A50123C00045ADVANCED RESEARCH AND DEVELOPMENT ACTIVITIES FOR NOVEL IMMUNOGENICITY ASSAYS AND SAMPLE COLLECTION TECHNOLOGIES AS PART OF BARDA?S CONTINUING SUPPORT FOR COVID-19 VACCINE DEVELOPMENT, ASSESSING IMPACT OF VARIANTS ON VACCINE IMMUNOGENICITY, AND ANALYZDepartment of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseWILMINGTON, NC-07$126,485,055Ends September 28, 2029
75A50124C00001BARDA WILL IMPLEMENT A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2 TRIAL IN THE US TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL HOST-DIRECTED THERAPEUTIC CANDIDATES IN HOSPITALIZED ADULTS WITH ARDS.Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseWILMINGTON, NC-07$117,399,278Ends September 30, 2030
75N93024F00001NIAID CLINICAL SITE MONITORING (NCSM)Department of Health and Human ServicesNational Institutes of HealthWILMINGTON, NC-07$73,196,564Ends January 31, 2027
75N93022C00014NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC)Department of Health and Human ServicesNational Institutes of HealthWILMINGTON, NC-07$36,391,559Ends June 29, 2027
HHSN272201200004CTAS::75 0885::TAS NIAID DAIT CLINICAL SITE MONITORING CENTERDepartment of Health and Human ServicesNational Institutes of HealthWILMINGTON, NC-07$27,036,076.33Ends August 20, 2026
75N93024F00002COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS)Department of Health and Human ServicesNational Institutes of HealthWILMINGTON, NC-07$26,101,778Ends August 14, 2027
HHSN272201200002CR&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)Department of Health and Human ServicesNational Institutes of HealthWILMINGTON, NC-07$21,947,371.89Ends October 31, 2021
75N93022C00001REGULATORY MANAGEMENT CENTER (RMC)Department of Health and Human ServicesNational Institutes of HealthWILMINGTON, NC-07$20,372,255Ends October 31, 2027
75N93019F00131TO PROVIDE MONITORING SERVICES FOR ONE (1) PHASE III CLINICAL TRIAL, A5300B/PHOENIXDepartment of Health and Human ServicesNational Institutes of HealthWILMINGTON, NC-07$5,696,076.64Ends December 14, 2025
75N93026F00001DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX)Department of Health and Human ServicesNational Institutes of HealthWILMINGTON, NC-07$3,092,829Ends December 14, 2026
75N93023F00001EPCTUDepartment of Health and Human ServicesNational Institutes of HealthWILMINGTON, NC-07$2,791,811Ends January 31, 2026
75D30121C11269TBTC MONITORINGDepartment of Health and Human ServicesCenters for Disease Control and PreventionWILMINGTON, NC-07$2,054,175.16Ends June 27, 2024
75N98026F00001TASK ORDER AWARD- PHASE I CLINICAL TRIALS FOR THE DEVELOPMENT OF NEUROTHERAPEUTICS- DTI-117 IN HEALTHY VOLUNTEERS/SAD AND MAD CTDepartment of Health and Human ServicesNational Institutes of HealthWILMINGTON, NC-07$2,016,831Ends April 28, 2027
75F40124C00134BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS.Department of Health and Human ServicesFood and Drug AdministrationWILMINGTON, NC-07$1,299,218Ends November 22, 2027
75N93022F00001TASK ORDER 75N93022F00001 BASE AWARDDepartment of Health and Human ServicesNational Institutes of HealthWILMINGTON, NC-07$905,501Ends January 13, 2027
75F40124C00117FDABAA-24-00123, REF # FY24C1EP6, CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME PATIENT-REPORTED OUTCOME (PRO) BURDEN MEASUREDepartment of Health and Human ServicesFood and Drug AdministrationWILMINGTON, NC-07$724,461Ends July 15, 2027
75N92019C00005ACQUISITION TITLE: CLINICAL SITE AND STUDY MONITORING SUPPORT SERVICES FOR THE NATIONAL HEART, LUNG, AND BLOOD INSTITUTE'S HYPERTENSION OUTCOMES FOR T4 RESEARCH WITHIN LOWER MIDDLE-INCOME COUNTRIES (HY-TREC)Department of Health and Human ServicesNational Institutes of HealthBETHESDA, MD-08$654,560.53Ends July 25, 2023
75N95024F00001RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. CLINICAL STUDY PROTOCOL DEVELOPMENT. TASK ORDER 02. 06/17/2024 - 06/16/2029. BASE AND EXERCISE 2 UNITS OF OPTION QUANTITY 1.Department of Health and Human ServicesNational Institutes of HealthWILMINGTON, NC-07$324,420Ends June 16, 2029
75N95023F00001REGULATORY CONSULTING ASSISTANCE FOR MEDICAL DEVICE DEVELOPER. RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. TASK ORDER 02. 09/15/2023 - 09/14/2024.Department of Health and Human ServicesNational Institutes of HealthWILMINGTON, NC-07$63,603.26Ends December 31, 2024
75N93021F00001COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMSDepartment of Health and Human ServicesNational Institutes of HealthBETHESDA, MD-08$0Ends August 31, 2022

Subcontracts it reported

A prime contractor reports the subcontracts it gives under an award (first-tier subawards). These are the largest it reported under its three largest awards, from every year of each award.

No subcontract is reported under this vendor’s largest awards.

Lobbying reports and campaign receipts that name this vendor

No lobbying report, organization page or FEC receipt in our saved records has this vendor’s name or its parent company’s name.

A name is matched only when it is the same name under the exact-name rule: letters and numbers alike, "&" read as "and", a leading "the" and one closing legal form (Inc, LLC, Corp, Corporation, Co, LP, LLP) set aside. A near name is never a match. Each match says which name matched.

Suggest a tool

Suggest a tool

A person reads each idea before it appears. Links are not accepted. Do not include personal information.

See all ideas and vote